Stefano Ronchi - DiaSorin SpA Sr. Corporate VP of HR

All Insiders . USA . 
Stock . DiaSorin SpA . Stakeholders . Insider . Stefano Ronchi
DSRLF Stock  USD 106.85  0.32  0.30%   

VP

Mr. Stefano Ronchi has served as Senior Corporationrationrate Vice President Human Resources at Diasorin S.p.A. since January 2007. From 1987 to 2006, he worked for Fiat Group, where he held various Human Resources positions, including V.P. Human Resources Comau w.w. In 2007, he joined DiaSorin S.p.A. He graduated in Law from Universita degli Studi di Roma La Sapienza. since 2007.
Age 63
Tenure 17 years
Phone39 01 614871
Webhttps://diasoringroup.com

DiaSorin SpA Management Efficiency

The company has return on total asset (ROA) of 0.0902 % which means that it generated a profit of $0.0902 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.198 %, meaning that it generated $0.198 on every $100 dollars invested by stockholders. DiaSorin SpA's management efficiency ratios could be used to measure how well DiaSorin SpA manages its routine affairs as well as how well it operates its assets and liabilities.
DiaSorin SpA has accumulated 1.23 B in total debt with debt to equity ratio (D/E) of 0.93, which is about average as compared to similar companies. DiaSorin SpA has a current ratio of 4.11, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist DiaSorin SpA until it has trouble settling it off, either with new capital or with free cash flow. So, DiaSorin SpA's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like DiaSorin SpA sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for DiaSorin to invest in growth at high rates of return. When we think about DiaSorin SpA's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

VP Age

Sharon JDIDEXX Laboratories
63
Jenipher DaltonAgilent Technologies
N/A
Alexander JDSotera Health Co
65
Masoud ToloueRevvity
44
Kerri JosephIQVIA Holdings
N/A
Bret DiMarcoAgilent Technologies
56
Eric JDIQVIA Holdings
60
Jason PetersonSotera Health Co
N/A
Andrew OkunRevvity
54
Lisa BrittThermo Fisher Scientific
56
Gina MullaneCharles River Laboratories
N/A
Jeffrey MDIQVIA Holdings
N/A
Keriann CherofskyIQVIA Holdings
39
Diana ChiuAgilent Technologies
N/A
Robert WernerTwist Bioscience Corp
51
Keeley JDWaters
47
Dennis ChoTwist Bioscience Corp
53
Brian JDDanaher
57
Simon MayAgilent Technologies
52
Matthew JDCharles River Laboratories
N/A
Matthew DanielCharles River Laboratories
N/A
DiaSorin S.p.A. develops, manufactures, and distributes immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company was founded in 1968 and is headquartered in Saluggia, Italy. DIASORIN SPA operates under Diagnostics Research classification in the United States and is traded on OTC Exchange. It employs 3350 people. DiaSorin SpA [DSRLF] is a Pink Sheet which is traded through a dealer network over-the-counter (OTC).

Management Performance

Return On Equity0.2
Return On Asset0.0902

DiaSorin SpA Leadership Team

Elected by the shareholders, the DiaSorin SpA's board of directors comprises two types of representatives: DiaSorin SpA inside directors who are chosen from within the company, and outside directors, selected externally and held independent of DiaSorin. The board's role is to monitor DiaSorin SpA's management team and ensure that shareholders' interests are well served. DiaSorin SpA's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, DiaSorin SpA's outside directors are responsible for providing unbiased perspectives on the board's policies.
Fabrizio Bonelli, Chief Officer
Carlo Rosa, CEO, General Manager and Executive Director
Piergiorgio Pedron, Senior Corporate VP and CFO
Ulisse Spada, Mang Department
Angelo Rago, Pres Corp
Stefano Ronchi, Sr. Corporate VP of HR
Ugo Gay, Sr Operations
Chen Even, Chief Commercial Officer and Executive Director
Riccardo Fava, Director of Investor Relations and Corporate Communication

DiaSorin Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is DiaSorin SpA a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity0.2
Return On Asset0.0902
Profit Margin0.20 %
Operating Margin0.29 %
Current Valuation8.64 B
Shares Outstanding53.84 M
Shares Owned By Insiders57.50 %
Shares Owned By Institutions22.36 %
Price To Earning26.36 X
Price To Book4.73 X

Currently Active Assets on Macroaxis

CCitigroup
GMGeneral Motors
FFord Motor
GMGeneral Motors
VVisa Class A

Other Information on Investing in DiaSorin Pink Sheet

DiaSorin SpA financial ratios help investors to determine whether DiaSorin Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in DiaSorin with respect to the benefits of owning DiaSorin SpA security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY